Research - Didcot, England, United Kingdom
Kinetic Discovery Ltd. offers drug discovery services as hit identification, confirmation and validation using surface plasmon resonance biosensors (Biacore). Our sensitive technology can be used to determine affinity of target/analyte interaction, kinetics of binding or screen compounds with molecular weight as low as 100 Da.Currently we are utilizing seven SPR instruments: 2x Biacore T200, Biacore S200, 2x Biacore 3000, Biacore 4000 and Sierra MASS-2. Kinetic Discovery currently offers FRAGMENT SCREENING services using either our own specially selected fragment library or a customer's collection.New services include assay development, transfer and consultancy package enabling a customer to optimise the use of their SPR technology investments 'in-house' as well as training in using SPR technology.Kinetic Discovery operates on competitive prices and provides exceptional quality data.For more information please email us at contact@kineticdiscovery.com.
Mimecast
Atlassian Cloud
Microsoft Office 365
Amazon AWS